BETASERON [INTERFERON BETA-1B] FOR SC INJECTION MEDICATION + SUPPORT
Dead / Cancelled — Cancelled — Section 8 (as of 21 Jun 2019)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85054653
- Registration number
- 4246421
- Mark type
- Design + words
- Filed
- 04 Jun 2010
- Published for opposition
- 14 Dec 2010
- Registered
- 20 Nov 2012
- Attorney of record
- Vanessa A. Ignacio
Goods and services
- Class 044 — Medical, beauty and agricultural services: medical services in the field of multiple sclerosis
Owner
- BAYER INTELLECTUAL PROPERTY GMBH, MONHEIM AM RHEIN, DE
- BAYER PHARMA AKTIENGESELLSCHAFT, BERLIN, DE
- Bayer Schering Pharma Aktiengesellschaft, Berlin, DE
- Bayer Schering Pharma Aktiengesellschaft, Berlin, DE
- Bayer Schering Pharma Aktiengesellschaft, Berlin, DE
Prior registrations
Prosecution history
- 21 Jun 2019 — CANCELLED SEC. 8 (6-YR)
- 14 Feb 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Feb 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Nov 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Aug 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Dec 2013 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Nov 2012 — REGISTERED-PRINCIPAL REGISTER
- 16 Oct 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Oct 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 10 Oct 2012 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Oct 2012 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Oct 2011 — USE AMENDMENT FILED
- 03 Nov 2011 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2011 — SOU EXTENSION 2 GRANTED
- 31 Oct 2011 — SOU EXTENSION 2 FILED